Hospital Pablo Tobon Uribe
Medellín, Antioquia, Colombia
NCT Number: NCT00096421
The purpose of this study is to evaluate the impact of tight control of serum glucose levels with an intensive insulin treatment in patients hospitalized in an intensive care unit with medical and surgical patients.
Looking for future studies?
Notify Me15 year and older
All sexes
Interventional
Phase 3
Medellín, Antioquia, Colombia
Reduction of morbidity-mortality in critical care patients with tight glycemic control had been proven in surgical patients only.
Study Hypothesis: In critical care patients, medical or surgical, a glucose serum level between 80 - 110 mg/dL means a lower mortality than patients with glucose levels of more than 110 mg/dL.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hospital Pablo Tobón Uribe
Other
Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit: A Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01233726
Critical Illness, Dietary Modification
Madrid, Spain
View Trial DetailsNCT01002482
Critical Illness, Disease Attributes
Amiens, France
View Trial DetailsNCT07385391
Critical Illness, Disease Attributes
Nanjing, Jiangsu, China
View Trial DetailsNCT03890432
Critical Illness, Deficiency Diseases
Geneva, Canton of Geneva, Switzerland
View Trial Details